1. Home
  2. ONCO vs AMBO Comparison

ONCO vs AMBO Comparison

Compare ONCO & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • AMBO
  • Stock Information
  • Founded
  • ONCO 2018
  • AMBO 2000
  • Country
  • ONCO United States
  • AMBO United States
  • Employees
  • ONCO N/A
  • AMBO N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • ONCO Health Care
  • AMBO Real Estate
  • Exchange
  • ONCO Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • ONCO 9.4M
  • AMBO 7.2M
  • IPO Year
  • ONCO 2022
  • AMBO 2010
  • Fundamental
  • Price
  • ONCO $0.55
  • AMBO $2.50
  • Analyst Decision
  • ONCO
  • AMBO
  • Analyst Count
  • ONCO 0
  • AMBO 0
  • Target Price
  • ONCO N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • ONCO 9.9M
  • AMBO 128.3K
  • Earning Date
  • ONCO 04-10-2025
  • AMBO 12-30-2024
  • Dividend Yield
  • ONCO N/A
  • AMBO N/A
  • EPS Growth
  • ONCO N/A
  • AMBO N/A
  • EPS
  • ONCO N/A
  • AMBO N/A
  • Revenue
  • ONCO $1,870,605.00
  • AMBO $7,839,000.00
  • Revenue This Year
  • ONCO N/A
  • AMBO N/A
  • Revenue Next Year
  • ONCO N/A
  • AMBO N/A
  • P/E Ratio
  • ONCO N/A
  • AMBO N/A
  • Revenue Growth
  • ONCO N/A
  • AMBO N/A
  • 52 Week Low
  • ONCO $0.32
  • AMBO $1.00
  • 52 Week High
  • ONCO $21.40
  • AMBO $6.30
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 44.65
  • AMBO 53.53
  • Support Level
  • ONCO $0.53
  • AMBO $2.41
  • Resistance Level
  • ONCO $0.70
  • AMBO $2.80
  • Average True Range (ATR)
  • ONCO 0.06
  • AMBO 0.31
  • MACD
  • ONCO 0.00
  • AMBO -0.01
  • Stochastic Oscillator
  • ONCO 22.17
  • AMBO 50.00

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

Share on Social Networks: